Institutional Ownership Rhythm Pharmaceuticals, Inc. (RYTM)
This table provides information about the institutional ownership of Rhythm Pharmaceuticals, Inc. (RYTM). We have compiled data on the 282 institutions that hold shares in the stock, with a total of 486 Million shares, which have been reported (via 13F filing form) to have a value of $48.3 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
215,152
shares
|
$21.4 Million
0.74% of portfolio
|
Q3 2025
Reduced 13.42%
|
|
|
Comerica Bank
|
Nov 13, 2025 Q3 2025 |
209,325
shares
|
$20.8 Million
0.08% of portfolio
|
Q3 2025
Reduced 30.61%
|
|
|
Logos Global Management LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
200,000
shares
|
$19.9 Million
2.34% of portfolio
|
Q3 2025
Added 53.85%
|
|
|
First Light Asset Management, LLC
Edina, MN |
Nov 14, 2025 Q3 2025 |
180,484
shares
|
$17.9 Million
2.19% of portfolio
|
Q3 2025
New holding
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 13, 2025 Q3 2025 |
171,834
shares
|
$17.1 Million
0.02% of portfolio
|
Q3 2025
Reduced 54.33%
|
|
|
Russell Investments Group, Ltd.
|
Nov 13, 2025 Q3 2025 |
157,678
shares
|
$15.7 Million
0.02% of portfolio
|
Q3 2025
Added 20.37%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
146,903
shares
|
$14.6 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.66%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
143,555
shares
|
$14.3 Million
0.0% of portfolio
|
Q3 2025
Added 108.28%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
142,385
shares
|
$14.2 Million
0.0% of portfolio
|
Q3 2025
Reduced 59.46%
|
|
|
Algert Global LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
140,284
shares
|
$13.9 Million
0.24% of portfolio
|
Q3 2025
Added 132.96%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2025 Q3 2025 |
137,967
shares
|
$13.7 Million
0.0% of portfolio
|
Q3 2025
Reduced 20.28%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
133,161
shares
|
$13.2 Million
0.01% of portfolio
|
Q3 2025
Reduced 32.78%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
132,626
shares
|
$13.2 Million
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Man Group PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
129,330
shares
|
$12.9 Million
0.02% of portfolio
|
Q3 2025
New holding
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Nov 14, 2025 Q3 2025 |
125,786
shares
|
$12.5 Million
0.0% of portfolio
|
Q2 2025
Added 149698.47%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Nov 13, 2025 Q3 2025 |
121,260
shares
|
$12.1 Million
0.04% of portfolio
|
Q3 2025
Added 5.34%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
117,964
shares
|
$11.7 Million
0.0% of portfolio
|
Q3 2025
Reduced 3.19%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2025 Q3 2025 |
116,742
shares
|
$11.6 Million
0.0% of portfolio
|
Q3 2025
Added 217.41%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Nov 13, 2025 Q3 2025 |
111,544
shares
|
$11.1 Million
0.02% of portfolio
|
Q3 2025
Added 531.66%
|
|
|
Swiss National Bank
Zurich, V8 |
Nov 13, 2025 Q3 2025 |
102,300
shares
|
$10.2 Million
0.01% of portfolio
|
Q3 2025
Added 14.56%
|
|
|
Universal Beteiligungs Und Servicegesellschaft Mb H
Frankfurt Am Main, 2M |
Oct 30, 2025 Q3 2025 |
101,372
shares
|
$10.1 Million
0.02% of portfolio
|
Q3 2025
Added 6.13%
|
|
|
Stem Point Capital LP
New York, NY |
Nov 14, 2025 Q3 2025 |
91,444
shares
|
$9.09 Million
1.85% of portfolio
|
Q3 2025
Reduced 48.26%
|
|
|
Pdt Partners, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
86,136
shares
|
$8.56 Million
0.6% of portfolio
|
Q3 2025
Reduced 11.78%
|
|
|
Neuberger Berman Group LLC
New York, NY |
Nov 12, 2025 Q3 2025 |
85,117
shares
|
$8.46 Million
0.01% of portfolio
|
Q3 2025
Reduced 1.19%
|
|
|
Axiom Investors LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
83,031
shares
|
$8.25 Million
0.06% of portfolio
|
Q3 2025
Added 58.27%
|
|